Taylor J R, Elsworth J D, Lawrence M S, Sladek J R, Roth R H, Redmond D E
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Exp Neurol. 1999 Jul;158(1):214-20. doi: 10.1006/exnr.1999.7093.
Previous studies have suggested a dopaminergic regulation of eye blink rates in human and nonhuman primates. Blockade of either dopamine (DA) D1 or DA D2 receptors or DA depletion induced by the dopaminergic neurotoxin MPTP both decrease spontaneous eye blink rates in monkeys. MPTP-induced decreases in blink rates can be reversed by administration of the full efficacy D1 agonist dihydrexidine, which has also been found to have dramatic antiparkinsonian effects in MPTP-treated animals. Increases in blink rates can also be induced by D1 and D2 agonists in normal animals. In the current study, we have investigated whether blink rates correlate with concentrations of DA or HVA and/or HVA:DA ratios in specific brain regions in MPTP-treated monkeys. Furthermore, the potential relationship between the severity of behavioral indices of parkinsonism and blink rates were examined. We found that (1) blink rates significantly correlate positively with concentration of DA and inversely with HVA:DA ratios in the rostral portion of the ventromedial body of the caudate nucleus (CD), but not other subcortical regions, and (2) that severity of parkinsonism was inversely correlated with blink rate. These data support a dopaminergic regulation of blink rate and suggest that the ventromedial region of the body of the CD may be critically involved in regulation of blink rate.
先前的研究表明,多巴胺能对人类和非人类灵长类动物的眨眼频率进行调节。阻断多巴胺(DA)D1或DA D2受体,或由多巴胺能神经毒素MPTP诱导的DA耗竭,都会降低猴子的自发眨眼频率。MPTP诱导的眨眼频率降低可通过给予完全有效的D1激动剂二氢麦角隐亭来逆转,该激动剂在MPTP处理的动物中也被发现具有显著的抗帕金森病作用。在正常动物中,D1和D2激动剂也可诱导眨眼频率增加。在本研究中,我们调查了MPTP处理的猴子中,眨眼频率是否与特定脑区中DA或高香草酸(HVA)的浓度和/或HVA:DA比值相关。此外,还检查了帕金森病行为指标的严重程度与眨眼频率之间的潜在关系。我们发现:(1)眨眼频率与尾状核腹内侧体头部(CD)中DA的浓度显著正相关,与HVA:DA比值呈负相关,但与其他皮层下区域无关;(2)帕金森病的严重程度与眨眼频率呈负相关。这些数据支持多巴胺能对眨眼频率的调节作用,并表明CD体的腹内侧区域可能在眨眼频率调节中起关键作用。